Fisetin, also known as 3,7,3',4'-tetrahydroxyflavone, is a naturally occurring flavonoid polyphenol compound that is found in a variety of fruits, vegetables, and Chinese medicinal materials such as cotinus and sumac. Ebos Biotech is proud to offer pure fisetin powder, a product that has gained attention for its potential health benefits. Fisetin is widely recognized for its role in brain and memory health, antioxidant and immune-enhancing effects, and applications in health and beauty.
Fisetin has been shown to cross the blood-brain barrier and act as a nootropic and neurotrophic agent that may have beneficial effects on the brain and memory. This makes it a promising ingredient for cognitive health support. In addition, fisetin is believed to have dual effects of antioxidant and immune enhancement, helping to improve human health and prevent disease. Its broad application prospects in the field of health care include its effects in antioxidant, anti-inflammatory, anti-cancer, and cardiovascular health protection.
In the nutraceutical industry, fisetin has shown professional value, especially in anti-inflammatory and immune modulation. Its potential applications in medicine, nutraceuticals and cosmetics, particularly in anti-aging and skin care products, make it a versatile ingredient. In addition, fisetin also shows potential in the field of cosmetics. It has antioxidant, anti-inflammatory, whitening and other effects, and is suitable for use in skin care products and medical cosmetology.
Ebos Biotech Co., Ltd. is committed to providing high-quality natural extracts, and our pure fisetin powder is no exception. Fisetin has the potential to support brain and memory health, enhance antioxidant and immune function, and has broad applications in health care and cosmetics, making it a valuable addition to a variety of products. Fisetin powder is a compelling choice for formulators in the food, beverage, health, cosmetic and pharmaceutical industries when looking for natural, scientifically-backed ingredients.
Post time: Jun-21-2024
